LONDON, September 6 /PRNewswire/ -- AstraZeneca today announced enrolment of the first patient in the new GRAVITY study Gauging the lipid effects of RosuvAstatin plus ezetimibe Versus sImvastatin plus ezetimibe TherapY. GRAVITY is a clinical tr LONDON, September 6 /PRNewswire/ -- ...
POMONA, Calif. -- Use of a controversial new cholesterol-lowering drug, ezetimibe (trade names: Zetia, Ezetrol, Vytorin), has increased in the United States, far beyond that seen in Canada, where direct-to-consumer advertising DTCA is prohibited and there is more government regulation of drug reimbursement in publicly-funded drug formularies. Worldwide sales for...
MERCK & Co. and Schering-Plough Pharmaceuticals have successfully completed the European Union EU Mutual Recognition Procedure for the ... MERCK & Co. and Schering-Plough Pharmaceuticals have successfully completed the European Union EU Mutual Recognition Procedure for the cholesterol-lowering drug Ezetrol ezetimibe, putting ...
THE $19 BILLION cholesterol market has been jolted by Food and Drug Administration FDA approval of Zetia ezetimibe, the first new class of drug behind a 15-year reign by statins. The development is good news for Schering-Plough Corp. SHP and THE $19 BILLION...
THE STATIN category got a new addition last month following FDA approval of Merck and Schering-Plough's Vytorin (ezetimibe/simvastatin), which combines Merck's Zocor and Zetia from Schering-Plough. Vytorin was expected in pharmacies by Labor Day.
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J. -- Merck and Schering-Plough said today that they strongly object to mischaracterizations about the ENHANCE (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia) trial. "While the ENHANCE trial was time consuming and...
Merck, Schering-Plough tap DDB for new account [whitehouse station and madison, n.j.] Joint marketers Merck & Co. and Schering-Plough Corp. have tapped DDB Worldwide, New York, to handle the launch of a developmental cholesterol-lowering drug known by its generic name ezetimibe, executives close to...
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
